| Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss R Cancello, C Henegar, N Viguerie, S Taleb, C Poitou, C Rouault, ... Diabetes 54 (8), 2277-2286, 2005 | 1411 | 2005 |
| Differential adaptation of human gut microbiota to bariatric surgery–induced weight loss: links with metabolic and low-grade inflammation markers JP Furet, LC Kong, J Tap, C Poitou, A Basdevant, JL Bouillot, D Mariat, ... Diabetes 59 (12), 3049-3057, 2010 | 1406 | 2010 |
| Links With Metabolic and Low-Grade Inflammation Markers JP Furet, LC Kong, J Tap, C Poitou, A Basdevant, JL Bouillot, D Mariat, ... | 1406* | 2010 |
| Weight loss regulates inflammation‐related genes in white adipose tissue of obese subjects K Clément, N Viguerie, C Poitou, C Carette, V Pelloux, CA Curat, A Sicard, ... The FASEB Journal 18 (14), 1657-1669, 2004 | 941 | 2004 |
| Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients P Bedossa, C Poitou, N Veyrie, JL Bouillot, A Basdevant, V Paradis, ... Hepatology 56 (5), 1751-1759, 2012 | 855 | 2012 |
| Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity R Cancello, J Tordjman, C Poitou, G Guilhem, JL Bouillot, D Hugol, ... Diabetes 55 (6), 1554-1561, 2006 | 745 | 2006 |
| Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss A Divoux, J Tordjman, D Lacasa, N Veyrie, D Hugol, A Aissat, ... Diabetes 59 (11), 2817-2825, 2010 | 606 | 2010 |
| Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity C Henegar, J Tordjman, V Achard, D Lacasa, I Cremer, M Guerre-Millo, ... Genome biology 9 (1), R14, 2008 | 494 | 2008 |
| Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss J Aron-Wisnewsky, J Tordjman, C Poitou, F Darakhshan, D Hugol, ... The Journal of Clinical Endocrinology & Metabolism 94 (11), 4619-4623, 2009 | 426 | 2009 |
| Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery H Sell, A Divoux, C Poitou, A Basdevant, JL Bouillot, P Bedossa, ... The Journal of Clinical Endocrinology & Metabolism 95 (6), 2892-2896, 2010 | 336 | 2010 |
| Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis P Richette, C Poitou, P Garnero, E Vicaut, JL Bouillot, JM Lacorte, ... Annals of the rheumatic diseases 70 (1), 139-144, 2011 | 310 | 2011 |
| Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients I Magalhaes, K Pingris, C Poitou, S Bessoles, N Venteclef, B Kiaf, ... The Journal of clinical investigation 125 (4), 1752-1762, 2015 | 298 | 2015 |
| CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis C Poitou, E Dalmas, M Renovato, V Benhamo, F Hajduch, M Abdennour, ... Arteriosclerosis, thrombosis, and vascular biology 31 (10), 2322-2330, 2011 | 273 | 2011 |
| AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial S Allas, A Caixàs, C Poitou, M Coupaye, D Thuilleaux, F Lorenzini, ... PloS one 13 (1), e0190849, 2018 | 253 | 2018 |
| Rare genetic forms of obesity: clinical approach and current treatments in 2016 H Huvenne, B Dubern, K Clément, C Poitou Obesity facts 9 (3), 158-173, 2016 | 253 | 2016 |
| MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency K Clément, H Biebermann, IS Farooqi, L Van der Ploeg, B Wolters, ... Nature medicine 24 (5), 551-555, 2018 | 251 | 2018 |
| Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency TH Collet, B Dubern, J Mokrosinski, H Connors, JM Keogh, ... Molecular metabolism 6 (10), 1321-1329, 2017 | 239 | 2017 |
| Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials K Clément, E van den Akker, J Argente, A Bahm, WK Chung, H Connors, ... The Lancet Diabetes & Endocrinology 8 (12), 960-970, 2020 | 234 | 2020 |
| Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition C Poitou, N Viguerie, R Cancello, R De Matteis, S Cinti, V Stich, ... Diabetologia 48 (3), 519-528, 2005 | 232 | 2005 |
| T cell–derived IL-22 amplifies IL-1β–driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes E Dalmas, N Venteclef, C Caer, C Poitou, I Cremer, J Aron-Wisnewsky, ... Diabetes 63 (6), 1966-1977, 2014 | 231 | 2014 |
